Characterization, monitoring and management of interstitial lung disease in patients with metastatic breast cancer: Analysis of data available from multiple studies of DS-8201a, a HER2-targeted antibody drug conjugate with a topoisomerase I inhibitor payload Meeting Abstract


Authors: Powell, C. A.; Camidge, D. R.; Gemma, A.; Kusumoto, M.; Baba, T.; Kuwano, K.; Bankier, A.; Kiura, K.; Tamura, K.; Modi, S.; Tsurutani, J.; Doi, T.; Iwata, H.; Krop, I. E.; Zhang, L.; Jasmeet, S.; Saito, K.; Shahidi, J.; Yver, A.; Takahashi, S.
Abstract Title: Characterization, monitoring and management of interstitial lung disease in patients with metastatic breast cancer: Analysis of data available from multiple studies of DS-8201a, a HER2-targeted antibody drug conjugate with a topoisomerase I inhibitor payload
Meeting Title: 41st Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 79
Issue: 4 Suppl.
Meeting Dates: 2018 Dec 4-10
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2019-02-01
Language: English
ACCESSION: WOS:000478677002274
DOI: 10.1158/1538-7445.Sabcs18-p6-17-06
PROVIDER: wos
Notes: Meeting Abstract: P6-17-06 -- Source: Wos
Altmetric Score
MSK Authors
  1. Shanu Modi
    144 Modi